Intuitive Surgical slips after narrowing its da Vinci procedure growth outlook

** Shares of robotic surgery technology firm Intuitive Surgical ISRG.O fall 7.6% to $404.7 premarket

** Co tightens its FY26 forecast for growth in procedures performed using its da Vinci robotic surgery systems

** Expects FY26 worldwide da Vinci procedure growth near midpoint of its 14%-15% range, vs prior view of 13.5%-15.5%

** ISRG posts Q3 adj. EPS and revenue of $3 and $3.05 bln, compared to analysts' estimates of $2.64 and $2.91 bln, according to data compiled by LSEG

** 25 of 35 brokerages rate the stock "buy" or higher, nine "hold" and one "sell"; median PT is $486

** As of last close, stock down 22.7% YTD